Portfolio company
Avelo
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops non-invasive breath sampling kits for the molecular diagnosis of respiratory infections like tuberculosis and pneumonia for clinicians and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alveo
This company develops portable molecular diagnostic platforms for rapid pathogen detection in agriculture, food safety, environmental monitoring, and human healthcare sectors.
Apieron
This company develops biosensor devices to monitor exhaled nitric oxide for asthma management in patients and clinical settings.
Aflo Analytics
This company develops a digital platform and connected sensor that monitors inhaler technique and adherence for patients with respiratory conditions and their clinicians.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Apreo
This clinical-stage medical device company develops an implantable airway scaffold to treat patients suffering from severe emphysema.
Acurable
This company develops wearable acoustic sensors and software for patients to monitor and diagnose obstructive sleep apnoea and other respiratory conditions at home.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
Pexa
The company develops non-invasive instruments to collect biomarkers from exhaled air for respiratory disease research and diagnosis for pharmaceutical firms, hospitals and academic institutions.
